Kai Pinkernell

Company: Glycostem Therapeutics
Job title: CMO
Seminars:
Off-the-Shelf NK Cells in European AML Clinical Trial 3:30 pm
Phase I/II a clinical trial in AML ongoing in the EU First outcomes at low doses Upcoming geographical and indication expansionRead more
day: Day One